Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s. Unlike most barbiturates it has little or no sedative effects instead acting as a non-sedating anxiolytic and antidepressant. The dosage range in humans is around 200–600 mg although higher doses have been used in trials for the treatment of depression associated with Parkinson’s disease.
This page contains content from the copyrighted Wikipedia article "Prazitone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
